Back to Atlas
APotentially durableResearch-only / high verification need
CMP-0144
Investigational
Trestolone acetate / MENT
Ergogenic / AAS
Potent anabolic-androgenic effect; male contraceptive research history
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Esterified 19-nor AAS
- Primary mechanism
- MENT prodrug; potent AR agonist; reported A:A ~2300:650
- Primary market use
- Male contraception / androgen replacement research
Pharmacology
- Molecular weight (Da)
- 330.46
- Oral bioavailability
- N/A (injectable/implant research); oral route not standard
- Half-life
- ~0.5-1 d acetate/release-dependent
- Route tags
- Route-dependent / verify
- Evidence level
- Human/clinical research
- Clinical status
- Investigational
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
A:A ratio is from preclinical androgen index; not a clinical safety metric.